Keston Aquino-Michaels

ORCID: 0009-0005-9077-3457
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cytokine Signaling Pathways and Interactions
  • Retinoids in leukemia and cellular processes
  • Nuclear Receptors and Signaling
  • Cancer-related molecular mechanisms research
  • Genetic Associations and Epidemiology
  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms
  • Hormonal Regulation and Hypertension
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Bioinformatics and Genomic Networks
  • Immune Cell Function and Interaction
  • Gene expression and cancer classification
  • Pharmacological Effects of Natural Compounds
  • Genetic Mapping and Diversity in Plants and Animals
  • Inflammatory mediators and NSAID effects
  • Lymphoma Diagnosis and Treatment
  • Dermatology and Skin Diseases
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Immune Response and Inflammation
  • MicroRNA in disease regulation
  • Gut microbiota and health
  • Ferroptosis and cancer prognosis
  • Adenosine and Purinergic Signaling

University of Chicago
2013-2025

PharmacoGenetics (China)
2011

T cell infiltration of solid tumors is associated with favorable patient outcomes, yet the mechanisms underlying variable immune responses between individuals are not well understood. One possible modulator could be intestinal microbiota. We compared melanoma growth in mice harboring distinct commensal microbiota and observed differences spontaneous antitumor immunity, which were eliminated upon cohousing or after fecal transfer. Sequencing 16S ribosomal RNA identified Bifidobacterium as...

10.1126/science.aac4255 article EN Science 2015-11-06

Understanding the genetic architecture of gene expression traits is key to elucidating underlying mechanisms complex traits. Here, for first time, we perform a systematic survey heritability and distribution effect sizes across all representative tissues in human body. We find that local h2 can be relatively well characterized with 59% expressed genes showing significant (FDR < 0.1) DGN whole blood cohort. However, current sample (n ≤ 922) do not allow us compute distal h2. Bayesian Sparse...

10.1371/journal.pgen.1006423 article EN cc-by PLoS Genetics 2016-11-11

Transplantation is the only cure for end-stage organ failure, but without immunosuppression, T cells rapidly reject allografts. While genetic disparities between donor and recipient are major determinants of kinetics transplant rejection, little known about contribution environmental factors. Because colonized organs have worse outcome than sterile organs, we tested influence host microbiota on skin rejection. Compared with untreated conventional mice, pretreatment donors recipients...

10.1172/jci85295 article EN Journal of Clinical Investigation 2016-06-19

High-confidence prediction of complex traits such as disease risk or drug response is an ultimate goal personalized medicine. Although genome-wide association studies have discovered thousands well-replicated polymorphisms associated with a broad spectrum traits, the combined predictive power these associations for any given trait generally too low to be clinical relevance. We propose novel systems approach prediction, which leverages and integrates similarity in genetic, transcriptomic,...

10.1002/gepi.21808 article EN Genetic Epidemiology 2014-05-02

Based on the notion that hypomorphic germline genetic variants are linked to autoimmune diseases, we reasoned novel targets for cancer immunotherapy might be identified through associated with greater T-cell infiltration into tumors. Here, report while investigating polymorphisms a tumor immune gene signature, PKCδ as candidate. Genetic deletion of in mice resulted improved endogenous antitumor immunity and increased efficacy anti-PD-L1. Single-cell RNA sequencing revealed myeloid cell...

10.1158/2326-6066.cir-23-0999 article EN Cancer Immunology Research 2025-01-14

&lt;div&gt;Abstract&lt;p&gt;Based on the notion that hypomorphic germline genetic variants are linked to autoimmune diseases, we reasoned novel targets for cancer immunotherapy might be identified through associated with greater T-cell infiltration into tumors. Here, report while investigating polymorphisms a tumor immune gene signature, protein kinase C delta (PKCδ) as candidate. Genetic deletion of &lt;i&gt;Prkcd&lt;/i&gt; in mice resulted improved endogenous antitumor immunity and...

10.1158/2326-6066.c.7749848 preprint EN 2025-04-02

&lt;p&gt;Hematopoietic loss of PKCδ via Vav1-iCre delays tumor growth and alters inflammatory gene expression in alternative “2C1”Prkcdfl/fl founder.&lt;/p&gt;

10.1158/2326-6066.28713791 preprint EN 2025-04-02

&lt;p&gt;Hematopoietic loss of PKCδ via Vav1-iCre delays tumor growth and alters inflammatory gene expression in “2B4”Prkcdfl/fl founder.&lt;/p&gt;

10.1158/2326-6066.28713797 preprint EN 2025-04-02

&lt;p&gt;Loss of PKCδ in myeloid cells delays tumor growth and is further delayed with anti-PD-L1 therapy multiple Prkcdfl/fl founders.&lt;/p&gt;

10.1158/2326-6066.28713788 preprint EN 2025-04-02

Little is known about genetic contributors to higher than usual warfarin dose requirements, particularly for African Americans. This study tested the hypothesis that γ-glutamyl carboxylase (GGCX) genotype contributes requirements greater 7.5 mg/day in an American population.

10.1097/fpc.0b013e32834f288f article EN Pharmacogenetics and Genomics 2011-12-12
Coming Soon ...